Invitro Diagnostics, Reagents, Test Kits, and Test Sets

Awarded Award Notice Posted

Solicitation number
M5-Q52A-04-R2
Agency
National Acquisition Center Headquarters, Department of Veterans Affairs
Awarded
to Bio Rad Laboratories Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
V797P4284B Federal IDV award
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

3 versions

Update #3 · Latest ·

Added: Oct 17, 2008 3:46 pm Modified: Oct 18, 2008 1:43 pmTrack Changes Federal Supply Schedule (FSS), FSC Group 65, Part VII - InvitroDiagnostics, Reagents, Test Kits and Test Sets. This solicitation hasbeen refreshed and is issued on an open and continuous basis and willnot contain a closing date for receipt of offers. New offers may besubmitted at any time. Performance will commence the effective date ofaward (DOA) and expire five years from that date, unless cancelled,terminated, or extended pursuant to any option provisions included inthe contract. This solicitation will result in multiple-year indefinitequantity, indefinite delivery contracts with Economic Price AdjustmentProvision. The resultant contracts will contain an Industrial FundingFee (IFF) provision. The solicitation will also include an option toextend the term of the contract. Request for solicitation may be faxedto the attention of Bob Satterfield at (708) 786-4975 or accessed atwww.fedbizopps.gov. All offers shall be in English language and in U.S.dollars. All interested vendors may submit an offer.

Update #2 ·

Added: Oct 17, 2008 3:46 pm Modified: Oct 18, 2008 9:46 amTrack Changes Federal Supply Schedule (FSS), FSC Group 65, Part VII - InvitroDiagnostics, Reagents, Test Kits and Test Sets. This solicitation hasbeen refreshed and is issued on an open and continuous basis and willnot contain a closing date for receipt of offers. New offers may besubmitted at any time. Performance will commence the effective date ofaward (DOA) and expire five years from that date, unless cancelled,terminated, or extended pursuant to any option provisions included inthe contract. This solicitation will result in multiple-year indefinitequantity, indefinite delivery contracts with Economic Price AdjustmentProvision. The resultant contracts will contain an Industrial FundingFee (IFF) provision. The solicitation will also include an option toextend the term of the contract. Request for solicitation may be faxedto the attention of Bob Satterfield at (708) 786-4975 or accessed atwww.fedbizopps.gov. All offers shall be in English language and in U.S.dollars. All interested vendors may submit an offer.

Update #1 ·

Added: Oct 17, 2008 3:46 pm Reagent and Diagnostic Schedule currently incorporates the following 10 commodity groups, and featuring approximately 70 contract in place for these various pharmaceutical product groups with Special Item Numbers (SIN): SIN 555-1 Blood Bank, Reagents/Controls, SIN 555-2 Chemistry, Reagents/Controls, Sin 555-3 Coagulation, Reagents/Controls, SIN 555-6 Microbiology, Reagents/Stains/Prepared Media/Collection System, SIN 555-7 Phlebotomy, Collection Tubes/Sets/Lancets/Skin Prep and SIN 555-8 Serology/Immunology, Reagents/Controls.

Attachments

Files attached to this notice, newest first
File Type Posted
M5-Q52A-04-R2-003.DOC DOC document
M5-Q52A-04-R2-001.DOC DOC document
M5-Q52A-04-R2-005.DOC DOC document
M5-Q52A-04-R2-008.XLS XLS spreadsheet
M5-Q52A-04-R2-002.DOC DOC document
M5-Q52A-04-R2-007.DOC DOC document
M5-Q52A-04-R2-006.DOC DOC document
M5-Q52A-04-R2-004.XLS XLS spreadsheet
M5-Q52A-04-R2-000.DOC DOC document

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
BBC Biochecmical Corporation FSC 65, Part VII - Invitro Diagnostics, Reagents, Test Kits and Sets Latest Award Notice
Invitro Diagnostics, Reagents, Test Kits, and Test Sets This notice · Original Award Notice

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity